Prognostic value of T1 substaging on oncological outcomes in patients with non-muscle-invasive bladder urothelial carcinoma: a systematic literature review and meta-analysis-Reference-Cited by-同舟云学术

Prognostic value of T1 substaging on oncological outcomes in patients with non-muscle-invasive bladder urothelial carcinoma: a systematic literature review and meta-analysis

Published:2019-09-06 Issue:6 Volume:38 Page:1437-1449
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Kardoust Parizi Mehdi,Enikeev Dmitry,Glybochko Petr V.,Seebacher Veronika,Janisch Florian,Fajkovic Harun,Chłosta Piotr L.,Shariat Shahrokh F.

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/content/pdf/10.1007/s00345-019-02936-y.pdf

Reference54 articles.

1. Soukup V, Capoun O, Cohen D, Hernandez V, Burger M, Comperat E, Gontero P, Lam T, Mostafid AH, Palou J, van Rhijn BWG, Roupret M, Shariat SF, Sylvester R, Yuan Y, Zigeuner R, Babjuk M (2018) Risk stratification tools and prognostic models in non-muscle-invasive bladder cancer: a critical assessment from the european association of urology non-muscle-invasive bladder cancer guidelines panel. Eur Urol Focus. https://doi.org/10.1016/j.euf.2018.11.005

2. Kluth LA, Xylinas E, Crivelli JJ, Passoni N, Comploj E, Pycha A, Chrystal J, Sun M, Karakiewicz PI, Gontero P, Lotan Y, Chun FK, Fisch M, Scherr DS, Shariat SF (2013) Obesity is associated with worse outcomes in patients with T1 high grade urothelial carcinoma of the bladder. J Urol 190(2):480–486. https://doi.org/10.1016/j.juro.2013.01.089

3. Fritsche HM, Burger M, Svatek RS, Jeldres C, Karakiewicz PI, Novara G, Skinner E, Denzinger S, Fradet Y, Isbarn H, Bastian PJ, Volkmer BG, Montorsi F, Kassouf W, Tilki D, Otto W, Capitanio U, Izawa JI, Ficarra V, Lerner S, Sagalowsky AI, Schoenberg M, Kamat A, Dinney CP, Lotan Y, Shariat SF (2010) Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. Eur Urol 57(2):300–309. https://doi.org/10.1016/j.eururo.2009.09.024

4. Tilki D, Shariat SF, Lotan Y, Rink M, Karakiewicz PI, Schoenberg MP, Lerner SP, Sonpavde G, Sagalowsky AI, Gupta A (2013) Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy. BJU Intern 111(8):1215–1221. https://doi.org/10.1111/j.1464-410X.2012.11455.x

5. Mari A, Kimura S, Foerster B, Abufaraj M, D’Andrea D, Hassler M, Minervini A, Roupret M, Babjuk M, Shariat SF (2019) A systematic review and meta-analysis of the impact of lymphovascular invasion in bladder cancer transurethral resection specimens. BJU Intern 123(1):11–21. https://doi.org/10.1111/bju.14417

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer;American Journal of Surgical Pathology;2023-09-22

2. Recent Advances in the Classification of Bladder Cancer – Updates from the 5th Edition of the World Health Organization Classification of the Urinary and Male Genital Tumors;Bladder Cancer;2023-03-31

3. En Bloc Resection Versus Conventional TURBT for T1HG Bladder Cancer: A Propensity Score-Matched Analysis;Annals of Surgical Oncology;2023-03-10

4. Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG;Minerva Urology and Nephrology;2023-03

5. The Many Faces of Muscle-Invasive Bladder Cancer: Histopathological and Molecular Characterization;Seminars in Radiation Oncology;2023-01